NovaGo Therapeutics
Research - Schlieren, Zurich, Switzerland
NovaGo Therapeutics Employees
NovaGo Therapeutics Details
NovaGo's fully human monoclonal antibodies have the potential to become a safe and effective treatment in ophthalmology and central nervous system indications. NovaGo's proprietary antibodies block the function of Nogo-A, one of the most potent and well-studied vascular and nerve growth inhibitors.
Website:
http://www.novagotherapeutics.com
Employees:
7
HQ:
41 43 300 52 63
Location:
Schlieren, Zurich, Switzerland
Revenue:
NovaGo Therapeutics Technologies
Email Providers
Outlook
Load Balancers
Apache
Fonts
Google Font API
Other
Mobile Friendly
CSS and JavaScript Libraries
Bootstrap Framework